Wei Ni, Ph.D. - Publications

Affiliations: 
2006 Michigan State University, East Lansing, MI 
Area:
Pharmacology, Physiology Biology

16 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Ni W, Watts SW, Ng M, Chen S, Glenn DJ, Gardner DG. Elimination of vitamin D receptor in vascular endothelial cells alters vascular function. Hypertension. 64: 1290-8. PMID 25201890 DOI: 10.1161/Hypertensionaha.114.03971  0.487
2008 Ni W, Zhou H, Diaz J, Murphy DL, Haywood JR, Watts SW. Lack of the serotonin transporter does not prevent mineralocorticoid hypertension in rat and mouse. European Journal of Pharmacology. 589: 225-7. PMID 18573249 DOI: 10.1016/J.Ejphar.2008.06.012  0.568
2008 Ni W, Geddes TJ, Priestley JR, Szasz T, Kuhn DM, Watts SW. The existence of a local 5-hydroxytryptaminergic system in peripheral arteries. British Journal of Pharmacology. 154: 663-74. PMID 18414394 DOI: 10.1038/Bjp.2008.111  0.666
2008 Linder AE, Ni W, Szasz T, Burnett R, Diaz J, Geddes TJ, Kuhn DM, Watts SW. A serotonergic system in veins: serotonin transporter-independent uptake. The Journal of Pharmacology and Experimental Therapeutics. 325: 714-22. PMID 18322152 DOI: 10.1124/Jpet.107.135699  0.646
2008 Diaz J, Ni W, Thompson J, King A, Fink GD, Watts SW. 5-Hydroxytryptamine lowers blood pressure in normotensive and hypertensive rats. The Journal of Pharmacology and Experimental Therapeutics. 325: 1031-8. PMID 18305011 DOI: 10.1124/Jpet.108.136226  0.648
2008 Linder AE, Diaz J, Ni W, Szasz T, Burnett R, Watts SW. Vascular reactivity, 5-HT uptake, and blood pressure in the serotonin transporter knockout rat. American Journal of Physiology. Heart and Circulatory Physiology. 294: H1745-52. PMID 18263707 DOI: 10.1152/Ajpheart.91415.2007  0.674
2007 Linder AE, Ni W, Diaz JL, Szasz T, Burnett R, Watts SW. Serotonin (5-HT) in veins: not all in vain. The Journal of Pharmacology and Experimental Therapeutics. 323: 415-21. PMID 17671100 DOI: 10.1124/Jpet.107.122630  0.664
2007 Ni W, Fink GD, Watts SW. The 5-hydroxytryptamine2A receptor is involved in (+)-norfenfluramine-induced arterial contraction and blood pressure increase in deoxycorticosterone acetate-salt hypertension. The Journal of Pharmacology and Experimental Therapeutics. 321: 485-91. PMID 17289838 DOI: 10.1124/Jpet.106.114017  0.629
2007 Ni W, Murphy DL, Watts SW. Existence of multiple 5‐HT uptake mechanisms in peripheral arteries The Faseb Journal. 21. DOI: 10.1096/Fasebj.21.5.A518-C  0.376
2007 Priestley JR, Ni W, Watts S. Endogenous serotonin potentiates norepinephrine‐induced contraction of the superior mesenteric artery The Faseb Journal. 21. DOI: 10.1096/Fasebj.21.5.A517-B  0.603
2006 Ni W, Watts SW. 5-hydroxytryptamine in the cardiovascular system: focus on the serotonin transporter (SERT). Clinical and Experimental Pharmacology & Physiology. 33: 575-83. PMID 16789923 DOI: 10.1111/J.1440-1681.2006.04410.X  0.598
2006 Ni W, Lookingland K, Watts SW. Arterial 5-hydroxytryptamine transporter function is impaired in deoxycorticosterone acetate and Nomega-nitro-L-arginine but not spontaneously hypertensive rats. Hypertension. 48: 134-40. PMID 16754787 DOI: 10.1161/01.Hyp.0000225754.15146.Dd  0.654
2006 Ni W, Lookingland K, Watts SW. Response to blood pressure in mutant rats lacking the 5-hydroxytryptamine transporter [8] Hypertension. 48: e117. DOI: 10.1161/01.Hyp.0000246309.64175.69  0.581
2005 Ni W, Wilhelm CS, Bader M, Murphy DL, Lookingland K, Watts SW. (+)-Norfenfluramine-induced arterial contraction is not dependent on endogenous 5-hydroxytryptamine or 5-hydroxytryptamine transporter. The Journal of Pharmacology and Experimental Therapeutics. 314: 953-60. PMID 15901794 DOI: 10.1124/Jpet.105.087080  0.645
2004 Ni W, Thompson JM, Northcott CA, Lookingland K, Watts SW. The serotonin transporter is present and functional in peripheral arterial smooth muscle. Journal of Cardiovascular Pharmacology. 43: 770-81. PMID 15167270 DOI: 10.1097/00005344-200406000-00006  0.736
2004 Ni W, Li MW, Thakali K, Fink GD, Watts SW. The fenfluramine metabolite (+)-norfenfluramine is vasoactive. The Journal of Pharmacology and Experimental Therapeutics. 309: 845-52. PMID 14752059 DOI: 10.1124/Jpet.103.060806  0.726
Show low-probability matches.